BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.010
-0.020 (-1.94%)
At close: Jun 27, 2025, 4:00 PM
0.9998
-0.0100 (-1.01%)
After-hours: Jun 27, 2025, 7:59 PM EDT
BioVie Employees
BioVie had 14 employees as of June 30, 2024. The number of employees decreased by 4 or -22.22% compared to the previous year.
Employees
14
Change (1Y)
-4
Growth (1Y)
-22.22%
Revenue / Employee
n/a
Profits / Employee
-$1,383,088
Market Cap
18.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BIVI News
- 2 days ago - BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD) - GlobeNewsWire
- 3 days ago - BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress - GlobeNewsWire
- 6 weeks ago - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025 - GlobeNewsWire
- 3 months ago - BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025 - GlobeNewsWire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Shareholders to Connect - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Shareholders to Reach Out - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Shareholders to Learn More About the Investigation - Accesswire